Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Desmoplakins | 1 | 2020 | 66 | 0.800 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2019 | 32 | 0.750 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2019 | 118 | 0.700 |
Why?
|
| Independent Living | 1 | 2022 | 540 | 0.650 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 428 | 0.550 |
Why?
|
| Urinary Bladder | 1 | 2019 | 1136 | 0.460 |
Why?
|
| China | 8 | 2022 | 2241 | 0.330 |
Why?
|
| Asthma | 2 | 2023 | 5945 | 0.310 |
Why?
|
| Gene Expression | 1 | 2020 | 7954 | 0.310 |
Why?
|
| Genetic Variation | 1 | 2020 | 6664 | 0.260 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 11940 | 0.240 |
Why?
|
| Anti-Ulcer Agents | 1 | 2004 | 116 | 0.240 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 258 | 0.230 |
Why?
|
| Mixed Function Oxygenases | 1 | 2004 | 316 | 0.220 |
Why?
|
| Opisthorchiasis | 1 | 2021 | 3 | 0.210 |
Why?
|
| Helicobacter pylori | 1 | 2004 | 328 | 0.210 |
Why?
|
| Helicobacter Infections | 1 | 2004 | 333 | 0.200 |
Why?
|
| Endemic Diseases | 1 | 2021 | 160 | 0.190 |
Why?
|
| Ice Cover | 1 | 2018 | 9 | 0.180 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2019 | 75 | 0.180 |
Why?
|
| Genetic Speciation | 1 | 2018 | 45 | 0.170 |
Why?
|
| Urinary Bladder Diseases | 1 | 2019 | 172 | 0.170 |
Why?
|
| Benzimidazoles | 1 | 2004 | 877 | 0.170 |
Why?
|
| Birds | 1 | 2018 | 154 | 0.170 |
Why?
|
| Sanitation | 1 | 2018 | 90 | 0.160 |
Why?
|
| Emphysema | 1 | 2019 | 218 | 0.160 |
Why?
|
| Oxonic Acid | 1 | 2016 | 45 | 0.150 |
Why?
|
| Tegafur | 1 | 2016 | 53 | 0.150 |
Why?
|
| Water Supply | 1 | 2018 | 208 | 0.150 |
Why?
|
| Biodiversity | 1 | 2018 | 350 | 0.140 |
Why?
|
| Travel | 1 | 2021 | 748 | 0.140 |
Why?
|
| Muscle, Smooth | 1 | 2019 | 944 | 0.140 |
Why?
|
| Muscle Contraction | 1 | 2019 | 1239 | 0.130 |
Why?
|
| Hand, Foot and Mouth Disease | 1 | 2012 | 24 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 2316 | 0.110 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 1152 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2020 | 1923 | 0.100 |
Why?
|
| Developing Countries | 2 | 2021 | 2737 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2019 | 2615 | 0.090 |
Why?
|
| Nepal | 2 | 2021 | 278 | 0.090 |
Why?
|
| Rabies Vaccines | 1 | 2008 | 31 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2019 | 4228 | 0.090 |
Why?
|
| Rabies | 1 | 2008 | 60 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3636 | 0.080 |
Why?
|
| Geography | 2 | 2021 | 691 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2016 | 1245 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 13643 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2022 | 8047 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5038 | 0.060 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2004 | 34 | 0.060 |
Why?
|
| Mice | 2 | 2023 | 80373 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2019 | 15058 | 0.060 |
Why?
|
| Clarithromycin | 1 | 2004 | 79 | 0.060 |
Why?
|
| Amoxicillin | 1 | 2004 | 146 | 0.060 |
Why?
|
| Omeprazole | 1 | 2004 | 106 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19905 | 0.060 |
Why?
|
| Air Pollution | 1 | 2015 | 2047 | 0.060 |
Why?
|
| Models, Biological | 1 | 2019 | 9809 | 0.060 |
Why?
|
| Laos | 1 | 2021 | 26 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17409 | 0.050 |
Why?
|
| Animals | 4 | 2023 | 169404 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22663 | 0.050 |
Why?
|
| Cambodia | 1 | 2021 | 183 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12305 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4057 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 9739 | 0.050 |
Why?
|
| Thailand | 1 | 2021 | 285 | 0.050 |
Why?
|
| Vietnam | 1 | 2021 | 390 | 0.050 |
Why?
|
| Humans | 15 | 2022 | 715818 | 0.050 |
Why?
|
| Arctic Regions | 1 | 2018 | 18 | 0.040 |
Why?
|
| Government Programs | 1 | 2021 | 269 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2018 | 243 | 0.040 |
Why?
|
| Pregnancy | 1 | 2019 | 27398 | 0.040 |
Why?
|
| Orotate Phosphoribosyltransferase | 1 | 2016 | 6 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2021 | 899 | 0.040 |
Why?
|
| Epithelium | 1 | 2022 | 1721 | 0.040 |
Why?
|
| Health Facilities | 1 | 2021 | 464 | 0.040 |
Why?
|
| Middle Aged | 5 | 2022 | 214666 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2019 | 23729 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11236 | 0.030 |
Why?
|
| Aged | 4 | 2022 | 162468 | 0.030 |
Why?
|
| Sulfur Dioxide | 1 | 2015 | 171 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 966 | 0.030 |
Why?
|
| Leucovorin | 1 | 2016 | 596 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1314 | 0.030 |
Why?
|
| Species Specificity | 1 | 2018 | 2599 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6552 | 0.030 |
Why?
|
| Demography | 1 | 2018 | 1625 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2018 | 991 | 0.030 |
Why?
|
| Nitrogen Dioxide | 1 | 2015 | 435 | 0.030 |
Why?
|
| Stroke | 1 | 2015 | 9507 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4352 | 0.030 |
Why?
|
| Ozone | 1 | 2015 | 456 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2016 | 1610 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 1928 | 0.030 |
Why?
|
| Phylogeny | 1 | 2018 | 2792 | 0.030 |
Why?
|
| Population Surveillance | 2 | 2012 | 2650 | 0.020 |
Why?
|
| Female | 5 | 2019 | 377229 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 14438 | 0.020 |
Why?
|
| Poverty | 1 | 2021 | 2620 | 0.020 |
Why?
|
| Genotype | 1 | 2004 | 12919 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5800 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3374 | 0.020 |
Why?
|
| Logistic Models | 1 | 2004 | 13623 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3579 | 0.020 |
Why?
|
| Bites and Stings | 1 | 2008 | 93 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7189 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 7015 | 0.020 |
Why?
|
| Adult | 4 | 2020 | 212279 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2015 | 2281 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7757 | 0.020 |
Why?
|
| Prevalence | 1 | 2021 | 14912 | 0.020 |
Why?
|
| Time Factors | 2 | 2018 | 40887 | 0.020 |
Why?
|
| Male | 5 | 2020 | 350352 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58326 | 0.010 |
Why?
|
| Incidence | 2 | 2012 | 20733 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2015 | 2632 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10666 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2012 | 5065 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 62040 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 12248 | 0.010 |
Why?
|
| United States | 1 | 2019 | 67910 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 56228 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 70879 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 85157 | 0.000 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_